Prenetics Raises $70M from Tencent Sale, Boosts Liquidity to $171M
Event summary
- Prenetics sold its 35% stake in Insighta to Tencent for $70M, closing on February 13, 2026.
- Total adjusted liquidity now stands at $171.1M, with $99.3M in cash and $35.2M in Bitcoin.
- Proceeds will fuel global expansion of IM8, Prenetics' premium health and longevity brand.
- Company operates with zero debt following the transaction.
- Q4 and full-year 2025 financial results to be announced February 18, 2026.
The big picture
Prenetics' sale to Tencent marks the culmination of its strategic shift toward IM8, positioning it as a pure-play consumer health contender. The $70M infusion underscores the sector's appetite for premium health brands, particularly those with celebrity backing and rapid revenue scaling. With $171M in adjusted liquidity and zero debt, Prenetics now has the financial firepower to compete globally against established players in the burgeoning longevity market.
What we're watching
- Execution Risk
- Whether Prenetics can sustain IM8's rapid growth trajectory while maintaining profitability.
- Market Dynamics
- How the premium consumer health sector evolves with increasing competition from legacy nutrition brands.
- Financial Strategy
- The pace at which Prenetics deploys its newly enhanced liquidity for M&A or product innovation.